Indication

Loffler syndrome

Loffler syndrome is a benign, self-limited form of pulmonary eosinophilia primarily affecting the respiratory system. Read more about Loffler syndrome

334 drugs 161 manufacturers

Advertisement

Drugs that treat it

Common Loffler syndrome therapies.

Showing 262–270 of 334 drugs

DEXAMETHASONE

GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61
PD-RX PHARM
Filter & compare in the drug finder →Opens the drug finder with Loffler syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Loffler syndrome.

Loffler syndrome is a benign, self-limited form of pulmonary eosinophilia primarily affecting the respiratory system.

It develops as a hypersensitivity response, most commonly triggered by the transpulmonary larval migration of helminthic parasites—such as *Ascaris lumbricoides*, *Strongyloides stercoralis*, or hookworms—or by hypersensitivity reactions to certain medications.

Clinically and radiographically, the condition is defined by mild or transient respiratory symptoms, such as a dry cough, dyspnea, and wheezing, occurring alongside peripheral blood eosinophilia and characteristic migratory, fleeting pulmonary opacities that typically resolve spontaneously within a month.

Personalize your experience

Follow Loffler syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it